Insmed to Host First-Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026
Insmed (Nasdaq: INSM) will release first-quarter 2026 financial results on Thursday, May 7, 2026 and host a conference call at 8:00 a.m. ET that day.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Insmed (Nasdaq: INSM) will release first-quarter 2026 financial results on Thursday, May 7, 2026 and host a conference call at 8:00 a.m. ET that day. Management will discuss financial results and provide a business update.
The live call will be webcast at www.insmed.com; a replay will be available by phone through May 14, 2026 and archived on the investor site for 90 days.
Details
News Market Reaction – INSM
On Apr 23, the day this news came out, INSM closed 0.45% below the previous close.
Data tracked by StockTitan Argus for the Apr 23 session.
Key Figures
- Results date
- May 7, 2026
- First-quarter 2026 financial results release
- Call time
- 8:00 a.m. ET
- Start of Q1 2026 conference call
- Replay end date
- May 14, 2026
- Telephone replay availability for the call
- Webcast archive length
- 90 days
- Duration call replay remains on company website
- Access code
- 7862189
- Investor conference call dial-in code
- US dial-in
- (888) 210-2654
- Domestic access number for live call
- International dial-in
- (646) 960-0278
- International access number for live call
- Market cap
- 30430835966
- Pre-news market capitalization
Previous Conferences,earnings Reports
-
Scheduled Q4 and full-year 2025 results call with standard access details.
-
Announced Q3 2025 results release and investor call timing and access info.
-
Set date and time for Q2 2025 financial results and webcasted call.
-
Outlined Q1 2025 results release date and investor conference call logistics.
-
Announced Q4 and full-year 2024 results timing and related investor call.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Insmed management will host a conference call for investors beginning at 8:00 a.m. ET on Thursday, May 7, 2026, to discuss financial results and provide a business update.
Shareholders and other interested parties may participate in the conference call by dialing (888) 210-2654 (
A replay of the conference call will be accessible approximately 1 hour after its completion through May 14, 2026, by dialing (800) 770-2030 (
About Insmed
Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's most advanced programs are in pulmonary and inflammatory conditions, including two therapies approved to treat chronic, debilitating lung diseases. The Company's early-stage programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue.
Headquartered in
Contact:
Investors:
Bryan Dunn
Vice President, Investor Relations
(646) 812-4030
investor.relations@insmed.com
Media:
Claire Mulhearn
Vice President, Corporate Communications
(862) 842-6819
media@insmed.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-host-first-quarter-2026-financial-results-conference-call-on-thursday-may-7-2026-302750941.html
SOURCE Insmed Incorporated
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.